Genomic Origin and EGFR-TKI Treatments of Pulmonary Adenosquamous Carcinoma
Annals of Oncology, 2020.
EGFREGFR-TKIadenosquamous carcinomaclonal origingenomic profile
Abstract Background Adenosquamous carcinoma (ASC) of the lung is a heterogeneous disease that is comprised of both adenocarcinoma components (ACC) and squamous cell carcinoma components (SCCC). Their genomic profile, genetic origin, and clinical management remain controversial. Patients and Methods Resected ASC and metastatic tumor...More
Full Text (Upload PDF)
PPT (Upload PPT)